「Levormeloxifene」の版間の差分

提供:脳科学辞典
ナビゲーションに移動 検索に移動
bsd>Ozzie10aaaa
(Cleaned up using AutoEd)
 
(1版 をインポートしました)
 

2025年3月18日 (火) 19:32時点における最新版

Levormeloxifene
ファイル:Levormeloxifene.svg
Systematic (IUPAC) name
1-(2-[4-[(3R,4R)-7-Methoxy-2,2-dimethyl-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenoxy]ethyl)pyrrolidine
Clinical data
Pregnancy cat. ?
Legal status ?
Identifiers
CAS number 78994-23-7 N
ATC code ?
PubChem CID 35805
ChemSpider 32935 YesY
UNII 9512UKZ352 YesY
ChEMBL CHEMBL301327 YesY
Synonyms Levomeloxifene; 6720-CDRI; NNC-460020
Chemical data
Formula C30H35NO3 
 N (what is this?)  (verify)

Levormeloxifene (INNTooltip International Nonproprietary Name; developmental code names 6720-CDRI, NNC-460020) is a selective estrogen receptor modulator (SERM) which was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss but did not complete development and hence was never marketed.[1] The development was stopped because of a high incidence of gynecological side effects during clinical trials.[2] Levormeloxifene is the levorotatory enantiomer of ormeloxifene, which, in contrast, has been marketed, though rather as a hormonal contraceptive.

See also

References

  1. "Levormeloxifene - AdisInsight".
  2. Ravn P, Nielsen TF, Christiansen C (2006). "What can be learned from the levormeloxifene experience?". Acta Obstet Gynecol Scand. 85 (2): 135–42. doi:10.1080/00016340500345691. PMID 16532904. S2CID 12872469.

External links


テンプレート:Genito-urinary-drug-stub